Regression of a renal-cell metastatic osseous lesion following treatment.
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D006811:Humerus; D007680:Kidney Neoplasms; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009392:Nephrectomy; D012673:Semustine / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D012673:Semustine; D014747:Vinblastine; D008525:Medroxyprogesterone